SynGap Missense Server

Table of SynGAP1 Isoform α2 (UniProt Q96PV0-1) Missense Variants.

c.dna Variant SGM Consensus Domain ClinVar gnomAD ESM1b AlphaMissense REVEL FoldX Rosetta Foldetta PremPS PROVEAN PolyPhen-2 HumDiv PolyPhen-2 HumVar FATHMM SIFT PAM Physical SASA Normalized B-factor backbone Normalized B-factor sidechain SynGAP Structural Annotation DOI
Clinical Status Review Subm. ID Allele count Allele freq. LLR score Prediction Pathogenicity Class Optimized Score Prediction Average ΔΔG Prediction StdDev ΔΔG Prediction ΔΔG Prediction ΔΔG Prediction Score Prediction pph2_prob Prediction pph2_prob Prediction Nervous System Score Prediction Prediction Status Conservation Sequences PAM250 PAM120 Hydropathy Δ MW Δ Average Δ Δ StdDev Δ StdDev Secondary Tertiary bonds Inside out GAP-Ras interface At membrane No effect MD Alert Verdict Description
c.467T>GF156CLikely PathogenicUncertain 1-13.658Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.297Likely Benign-3.54Deleterious0.999Probably Damaging0.990Probably Damaging3.92Benign0.00Affected-4-2-0.3-44.04
c.2719A>TS907CLikely BenignLikely Benign 1-6.685Likely Benign0.298Likely BenignLikely Benign0.113Likely Benign-2.34Neutral0.999Probably Damaging0.988Probably Damaging2.60Benign0.02Affected3.7750-13.316.06
c.401G>AS134NLikely BenignUncertain 1-5.534Likely Benign0.813Likely PathogenicAmbiguous0.075Likely Benign-1.62Neutral0.001Benign0.002Benign3.90Benign0.00Affected3.61511-2.727.03
c.2291A>GN764SLikely BenignBenign 1-3.149Likely Benign0.159Likely BenignLikely Benign0.058Likely Benign-0.84Neutral0.992Probably Damaging0.846Possibly Damaging2.65Benign0.61Tolerated3.646112.7-27.03
c.2294G>AS765NLikely BenignUncertain 1-5.098Likely Benign0.378AmbiguousLikely Benign0.094Likely Benign-0.94Neutral0.985Probably Damaging0.950Probably Damaging4.11Benign0.06Tolerated3.64611-2.727.03
c.2299A>GI767VLikely BenignUncertain 1-2.791Likely Benign0.064Likely BenignLikely Benign0.096Likely Benign0.10Neutral0.072Benign0.029Benign4.21Benign1.00Tolerated3.64643-0.3-14.03
c.2300T>CI767TLikely BenignUncertain 1-3.749Likely Benign0.252Likely BenignLikely Benign0.138Likely Benign-0.78Neutral0.625Possibly Damaging0.249Benign4.12Benign0.46Tolerated3.6460-1-5.2-12.05
c.4008G>CE1336DLikely BenignLikely Benign 1-3.344Likely Benign0.596Likely PathogenicLikely Benign0.062Likely Benign-1.92Neutral0.001Benign0.003Benign3.30Benign0.00Affected3.775230.0-14.03
c.3G>AM1ILikely BenignConflicting 3-5.397Likely Benign0.227Likely Benign-0.17Neutral0.001Benign0.000Benign4.25Benign0.00Affected4.321212.6-18.03
c.2305C>TL769FLikely BenignUncertain 1-5.044Likely Benign0.146Likely BenignLikely Benign0.060Likely Benign-0.89Neutral0.925Possibly Damaging0.510Possibly Damaging3.94Benign0.02Affected20-1.034.02
c.3977C>TP1326LLikely BenignUncertain 1-5.541Likely Benign0.115Likely BenignLikely Benign0.117Likely Benign-1.06Neutral0.999Probably Damaging0.994Probably Damaging3.62Benign0.00Affected3.775-3-35.416.04
c.406C>TR136WLikely PathogenicUncertain 2-10.453Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.237Likely Benign-4.71Deleterious0.965Probably Damaging0.416Benign3.45Benign0.00Affected3.6152-33.630.03
c.2270G>CG757ALikely BenignUncertain 1-2.626Likely Benign0.091Likely BenignLikely Benign0.066Likely Benign-0.45Neutral0.267Benign0.127Benign2.73Benign0.35Tolerated102.214.03
c.2210A>CQ737PLikely BenignUncertain 1-2.407Likely Benign0.054Likely BenignLikely Benign0.154Likely Benign-1.22Neutral0.005Benign0.013Benign2.78Benign0.04Affected4.073-101.9-31.01
c.458C>AT153NLikely BenignConflicting 3-0.739Likely Benign0.226Likely BenignLikely Benign0.161Likely Benign0.88Neutral0.888Possibly Damaging0.537Possibly Damaging4.23Benign0.81Tolerated3.61500-2.813.00
c.2215G>CE739QLikely BenignUncertain 1-2.846Likely Benign0.161Likely BenignLikely Benign0.071Likely Benign-1.06Neutral0.801Possibly Damaging0.339Benign2.57Benign0.00Affected4.322220.0-0.98
c.2216A>TE739VLikely BenignUncertain 1-3.136Likely Benign0.274Likely BenignLikely Benign0.085Likely Benign-1.86Neutral0.891Possibly Damaging0.575Possibly Damaging2.47Pathogenic0.00Affected4.322-2-27.7-29.98
c.2217G>CE739DLikely BenignUncertain 1-3.369Likely Benign0.062Likely BenignLikely Benign0.097Likely Benign-0.49Neutral0.002Benign0.005Benign2.59Benign0.00Affected320.0-14.03
c.453C>AD151ELikely BenignUncertain 1-5.662Likely Benign0.886Likely PathogenicAmbiguous0.142Likely Benign-2.02Neutral0.984Probably Damaging0.967Probably Damaging3.99Benign0.11Tolerated3.615320.014.03
c.43G>CA15PLikely BenignUncertain 1-3.436Likely Benign0.097Likely BenignLikely Benign0.146Likely Benign-0.23Neutral0.880Possibly Damaging0.123Benign4.09Benign0.00Affected1-1-3.426.04
c.223G>AE75KLikely BenignBenign/Likely benign 2-4.020Likely Benign0.358AmbiguousLikely Benign0.134Likely Benign-1.12Neutral0.748Possibly Damaging0.017Benign4.07Benign0.00Affected01-0.4-0.94
c.407G>CR136PLikely PathogenicUncertain 1-11.952Likely Pathogenic0.981Likely PathogenicLikely Pathogenic0.277Likely Benign-3.72Deleterious0.910Possibly Damaging0.578Possibly Damaging3.47Benign0.00Affected3.6150-22.9-59.07
c.2249G>AG750EUncertain 1-2.618Likely Benign0.413AmbiguousLikely Benign0.146Likely Benign-2.27Neutral1.000Probably Damaging0.982Probably Damaging2.49Pathogenic0.01Affected3.9950-2-3.172.06
c.2324G>CR775PLikely BenignBenign 1-5.072Likely Benign0.452AmbiguousLikely Benign0.168Likely Benign-0.79Neutral0.971Probably Damaging0.944Probably Damaging4.13Benign0.07Tolerated3.646-202.9-59.07
c.3977C>GP1326RLikely BenignUncertain 1-5.097Likely Benign0.240Likely BenignLikely Benign0.133Likely Benign-0.82Neutral0.999Probably Damaging0.994Probably Damaging3.62Benign0.00Affected3.7750-2-2.959.07
c.233G>TR78LLikely BenignUncertain 1-3.389Likely Benign0.635Likely PathogenicLikely Benign0.062Likely Benign-1.59Neutral0.385Benign0.021Benign3.84Benign0.00Affected-3-28.3-43.03
c.2408A>GK803RLikely BenignSH3-binding motifUncertain 1-2.281Likely Benign0.097Likely BenignLikely Benign0.018Likely Benign-1.52Neutral0.103Benign0.038Benign2.38Pathogenic0.00Affected3.77532-0.628.01
c.2414T>CL805PSH3-binding motifUncertain 1-4.661Likely Benign0.444AmbiguousLikely Benign0.272Likely Benign-3.40Deleterious0.975Probably Damaging0.767Possibly Damaging2.36Pathogenic0.00Affected3.775-3-3-5.4-16.04
c.3773A>GQ1258RLikely PathogenicCoiled-coilUncertain 1-10.971Likely Pathogenic0.931Likely PathogenicAmbiguous0.316Likely Benign-3.19Deleterious0.994Probably Damaging0.988Probably Damaging2.00Pathogenic0.00Affected11-1.028.06
c.2420A>TY807FLikely BenignSH3-binding motifUncertain 1-3.667Likely Benign0.073Likely BenignLikely Benign0.057Likely Benign0.14Neutral0.012Benign0.022Benign2.92Benign0.98Tolerated3.775734.1-16.00
c.373C>TP125SLikely BenignUncertain 1-3.769Likely Benign0.238Likely BenignLikely Benign0.121Likely Benign-3.57Deleterious0.580Possibly Damaging0.140Benign2.86Benign0.02Affected3.6151-10.8-10.04
c.3731G>AS1244NLikely PathogenicCoiled-coilUncertain 1-9.008Likely Pathogenic0.751Likely PathogenicLikely Benign0.154Likely Benign-1.87Neutral0.997Probably Damaging0.992Probably Damaging2.10Pathogenic0.15Tolerated3.77511-2.727.03
c.2443C>AR815SSH3-binding motifBenign 1-7.324In-Between0.950Likely PathogenicAmbiguous0.138Likely Benign-1.86Neutral0.999Probably Damaging0.997Probably Damaging2.67Benign0.02Affected0-13.7-69.11
c.2443C>GR815GSH3-binding motifUncertain 1-7.983In-Between0.854Likely PathogenicAmbiguous0.146Likely Benign-3.22Deleterious0.999Probably Damaging0.997Probably Damaging2.62Benign0.02Affected4.324-3-24.1-99.14
c.3721C>AL1241MCoiled-coilUncertain 1-5.881Likely Benign0.782Likely PathogenicLikely Benign0.167Likely Benign-1.43Neutral1.000Probably Damaging0.999Probably Damaging1.65Pathogenic0.00Affected42-1.918.03
c.2444G>TR815LLikely PathogenicSH3-binding motifUncertain 1-8.546Likely Pathogenic0.865Likely PathogenicAmbiguous0.175Likely Benign-3.06Deleterious0.999Probably Damaging0.997Probably Damaging2.63Benign0.03Affected4.324-2-38.3-43.03
c.3794G>CR1265TLikely PathogenicCoiled-coilLikely Pathogenic 1-10.129Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.529Likely Pathogenic-4.97Deleterious0.997Probably Damaging0.994Probably Damaging2.29Pathogenic0.00Affected3.775-1-13.8-55.08
c.2401G>AG801SLikely BenignSH3-binding motifUncertain 1-3.665Likely Benign0.087Likely BenignLikely Benign0.039Likely Benign-0.41Neutral0.009Benign0.019Benign2.76Benign0.48Tolerated4.32201-0.430.03
c.2343G>AM781ILikely BenignBenign 1-2.484Likely Benign0.323Likely BenignLikely Benign0.101Likely Benign0.05Neutral0.000Benign0.001Benign2.89Benign1.00Tolerated3.646122.6-18.03
c.3943T>CW1315RLikely BenignUncertain 10.205Likely Benign0.660Likely PathogenicLikely Benign0.114Likely Benign1.31Neutral0.000Benign0.001Benign4.37Benign0.91Tolerated3.7752-3-3.6-30.03
c.2350G>AA784TLikely BenignBenign 1-3.579Likely Benign0.089Likely BenignLikely Benign0.046Likely Benign1.23Neutral0.001Benign0.006Benign2.92Benign1.00Tolerated3.64610-2.530.03
c.391G>CG131RUncertain 1-6.564Likely Benign0.983Likely PathogenicLikely Pathogenic0.099Likely Benign-3.82Deleterious0.983Probably Damaging0.656Possibly Damaging3.92Benign0.00Affected3.615-2-3-4.199.14
c.3907G>AG1303SLikely BenignUncertain 1-2.271Likely Benign0.125Likely BenignLikely Benign0.155Likely Benign-0.19Neutral0.649Possibly Damaging0.433Benign2.84Benign0.18Tolerated10-0.430.03
c.3906G>CL1302FUncertain 1-5.674Likely Benign0.148Likely BenignLikely Benign0.211Likely Benign-2.70Deleterious0.960Probably Damaging0.657Possibly Damaging1.53Pathogenic0.00Affected20-1.034.02
c.3806T>AV1269ELikely PathogenicCoiled-coilUncertain 1-11.418Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.403Likely Benign-5.05Deleterious0.999Probably Damaging0.995Probably Damaging2.09Pathogenic0.00Affected3.775-2-2-7.729.98
c.2369C>GT790SLikely BenignSH3-binding motifUncertain 1-3.914Likely Benign0.123Likely BenignLikely Benign0.134Likely Benign-1.83Neutral0.997Probably Damaging0.989Probably Damaging2.39Pathogenic0.33Tolerated3.64611-0.1-14.03
c.37A>GI13VLikely BenignUncertain 1-2.497Likely Benign0.105Likely BenignLikely Benign0.110Likely Benign0.01Neutral0.000Benign0.000Benign4.25Benign0.00Affected43-0.3-14.03
c.379C>TR127WUncertain 1-4.776Likely Benign0.806Likely PathogenicAmbiguous0.118Likely Benign-2.98Deleterious0.989Probably Damaging0.420Benign3.88Benign0.00Affected2-33.630.03
c.2458T>AY820NUncertain 1-9.032Likely Pathogenic0.842Likely PathogenicAmbiguous0.143Likely Benign-1.53Neutral0.999Probably Damaging0.977Probably Damaging2.74Benign0.20Tolerated-2-2-2.2-49.07
c.484C>GR162GLikely BenignUncertain 1-6.985Likely Benign0.664Likely PathogenicLikely Benign0.190Likely Benign-0.73Neutral0.487Possibly Damaging0.272Benign4.09Benign0.78Tolerated3.744-2-34.1-99.14
c.1851G>TE617D
(3D Viewer)
Likely BenignGAPUncertain 1-1.349Likely Benign0.241Likely BenignLikely Benign0.322Likely Benign0.12Likely Benign0.10.80Ambiguous0.46Likely Benign0.07Likely Benign-0.01Neutral0.994Probably Damaging0.979Probably Damaging-1.35Pathogenic0.88Tolerated3.3735230.0-14.03
c.1964T>AL655Q
(3D Viewer)
Likely BenignGAPUncertain 1-5.278Likely Benign0.144Likely BenignLikely Benign0.139Likely Benign-0.01Likely Benign0.00.69Ambiguous0.34Likely Benign-0.15Likely Benign0.61Neutral0.955Possibly Damaging0.602Possibly Damaging3.59Benign0.65Tolerated3.3924-2-2-7.314.97229.9-8.60.00.00.40.0XPotentially BenignThe iso-butyl side chain of Leu655, located on the surface of an α helix (res. Ser641-Glu666), is not involved in any interactions in the WT simulations. In the variant simulations, the carboxamide side chain of Gln655 dynamically interacts with neighboring residues (e.g., Glu651, Glu656, Arg544) on the protein surface, with no negative structural effects.
c.59C>TP20LLikely BenignUncertain 3-3.289Likely Benign0.464AmbiguousLikely Benign0.100Likely Benign-0.44Neutral0.909Possibly Damaging0.713Possibly Damaging4.27Benign0.00Affected4.321-3-35.416.04
c.196C>GP66ALikely BenignUncertain 1-2.845Likely Benign0.891Likely PathogenicAmbiguous0.091Likely Benign-1.56Neutral0.805Possibly Damaging0.539Possibly Damaging4.04Benign0.00Affected4.3211-13.4-26.04
c.3250C>GP1084ALikely BenignUncertain 1-3.928Likely Benign0.066Likely BenignLikely Benign0.114Likely Benign-2.54Deleterious0.649Possibly Damaging0.157Benign4.05Benign0.35Tolerated3.775-113.4-26.04
c.1970G>TW657L
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.411Likely Pathogenic0.960Likely PathogenicLikely Pathogenic0.213Likely Benign0.14Likely Benign0.10.73Ambiguous0.44Likely Benign0.87Ambiguous-10.86Deleterious0.277Benign0.078Benign3.52Benign0.14Tolerated3.3924-2-24.7-73.05
c.1971G>CW657CLikely PathogenicGAPUncertain 1-12.035Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.463Likely Benign2.74Destabilizing0.31.69Ambiguous2.22Destabilizing1.30Destabilizing-11.06Deleterious1.000Probably Damaging0.982Probably Damaging3.43Benign0.03Affected-8-23.4-83.07
c.59C>GP20RLikely BenignUncertain 1-3.548Likely Benign0.434AmbiguousLikely Benign0.146Likely Benign-0.15Neutral0.972Probably Damaging0.804Possibly Damaging4.33Benign0.00Affected4.3210-2-2.959.07
c.1976C>TS659F
(3D Viewer)
Likely PathogenicGAPUncertain 1-10.925Likely Pathogenic0.662Likely PathogenicLikely Benign0.194Likely Benign-0.81Ambiguous0.1-0.25Likely Benign-0.53Ambiguous0.32Likely Benign-4.59Deleterious0.806Possibly Damaging0.171Benign3.39Benign0.05Affected3.3828-3-23.660.10221.3-61.20.00.00.60.4XPotentially BenignIn the WT simulations, the hydroxyl group of Ser659, located in a kink in the middle of the long α-helix (res. Ser641-Glu666), forms a hydrogen bond with the carboxylate group of Glu656. However, the phenol ring of the Phe659 side chain cannot form a similar hydrogen bond. Instead, it interacts with the hydrophobic isopropyl side chain of Val555 from the opposing α-helix (res. Ala533-Val560). This residue swap may therefore cause issues during protein folding.
c.597C>AN199K
(3D Viewer)
PHUncertain 1-8.198Likely Pathogenic0.686Likely PathogenicLikely Benign0.024Likely Benign-0.19Likely Benign0.10.03Likely Benign-0.08Likely Benign0.33Likely Benign-1.48Neutral0.276Benign0.083Benign4.27Benign0.13Tolerated3.47910-0.414.07207.821.5-0.11.50.10.0XUncertainAsn199, located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by a positively charged lysine. On the protein surface, both the carboxamide group of Asn199 and the amino group of Lys199 side chains can form hydrogen bonds with the backbone carbonyl groups of residues (e.g., Ala249) at the end of an α helix (res. Ala236-Lys251). However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.583G>CA195PLikely PathogenicLikely Pathogenic 1-9.715Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.152Likely Benign-3.03Deleterious0.997Probably Damaging0.916Probably Damaging4.00Benign0.04Affected3.5461-1-3.426.04
c.1957C>GL653VLikely BenignGAPUncertain 1-7.050In-Between0.301Likely BenignLikely Benign0.146Likely Benign3.28Destabilizing0.32.18Destabilizing2.73Destabilizing1.32Destabilizing-2.25Neutral0.227Benign0.039Benign3.28Benign0.08Tolerated210.4-14.03
c.1947G>CM649I
(3D Viewer)
Likely PathogenicGAPUncertain 1-9.361Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.449Likely Benign2.42Destabilizing0.21.96Ambiguous2.19Destabilizing1.01Destabilizing-3.99Deleterious0.672Possibly Damaging0.093Benign3.40Benign0.02Affected3.3827212.6-18.03243.721.50.00.10.00.1XPotentially BenignThe thioether side chain of Met649, located on an α helix (res. Ser641-Glu666), bridges Phe652, Phe648, and Phe639 in an inter-helix hydrophobic cavity in the WT simulations. In the variant simulations, the sec-butyl side chain of Ile649 maintains hydrophobic interactions with nearby residues, with no significant effects on the protein structure.However, methionine is known as a bridging motif for aromatic residues, and these Met-aromatic interactions are lost in the variant. Indeed, in the second variant simulation,the bridging of Phe652, Phe648 and Phe639 is completely lost. In reality, the effect could be more severe on the structure during the protein folding.
c.1855A>TT619S
(3D Viewer)
Likely PathogenicGAPUncertain 1-8.608Likely Pathogenic0.677Likely PathogenicLikely Benign0.602Likely Pathogenic1.09Ambiguous0.21.35Ambiguous1.22Ambiguous0.85Ambiguous-3.42Deleterious0.999Probably Damaging0.998Probably Damaging-1.30Pathogenic0.05Affected3.373511-0.1-14.03
c.1873C>GL625VLikely PathogenicGAPUncertain 1-11.319Likely Pathogenic0.833Likely PathogenicAmbiguous0.480Likely Benign1.80Ambiguous0.71.69Ambiguous1.75Ambiguous1.42Destabilizing-2.96Deleterious0.998Probably Damaging0.992Probably Damaging3.07Benign0.01Affected210.4-14.03
c.1877T>CI626TLikely PathogenicGAPUncertain 1-10.420Likely Pathogenic0.946Likely PathogenicAmbiguous0.640Likely Pathogenic2.94Destabilizing0.12.70Destabilizing2.82Destabilizing2.23Destabilizing-4.18Deleterious1.000Probably Damaging1.000Probably Damaging3.04Benign0.00Affected0-1-5.2-12.05
c.187G>AE63KLikely BenignUncertain 1-4.976Likely Benign0.894Likely PathogenicAmbiguous0.103Likely Benign-0.70Neutral0.458Possibly Damaging0.678Possibly Damaging3.98Benign0.00Affected4.32110-0.4-0.94
c.187G>CE63QLikely BenignUncertain 1-4.038Likely Benign0.687Likely PathogenicLikely Benign0.078Likely Benign-0.85Neutral0.659Possibly Damaging0.775Possibly Damaging3.90Benign0.00Affected4.321220.0-0.98
c.603T>AD201E
(3D Viewer)
Likely BenignPHBenign 1-2.640Likely Benign0.406AmbiguousLikely Benign0.165Likely Benign0.42Likely Benign0.21.99Ambiguous1.21Ambiguous0.23Likely Benign-0.69Neutral0.633Possibly Damaging0.108Benign4.30Benign1.00Tolerated3.469320.014.03258.7-24.80.90.1-0.30.2XUncertainAsp201, an acidic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another acidic residue, glutamate. The carboxylate groups of both Asp201 and Glu201 side chains form hydrogen bonds with the hydroxyl group of Ser221 in the simulations. Due to its shorter side chain, Asp201 can also hydrogen bond with the backbone amide groups of neighboring loop residues Ser204 and Asp203. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.1898T>CL633P
(3D Viewer)
Likely PathogenicGAPPathogenic/Likely path. 2-15.669Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.693Likely Pathogenic6.60Destabilizing0.210.15Destabilizing8.38Destabilizing2.42Destabilizing-6.97Deleterious1.000Probably Damaging1.000Probably Damaging2.70Benign0.00Affected3.3734-3-3-5.4-16.04193.265.10.00.00.10.0XPotentially PathogenicThe iso-butyl side chain of Leu633, located in the middle of an α helix (res. Glu617-Asn635), packs hydrophobically with nearby residues (e.g., Leu653, Val629, Leu551) in the WT simulations.In the variant simulations, the pyrrolidine side chain of Pro633 is not as optimal for hydrophobic packing as Leu633 in the WT. Additionally, proline lacks a free backbone amide group, so Pro633 cannot form a hydrogen bond with the backbone carbonyl group of Val629, which disrupts the continuity of the secondary structure element.
c.1913A>GK638R
(3D Viewer)
Likely BenignGAPUncertain 1-2.700Likely Benign0.110Likely BenignLikely Benign0.216Likely Benign0.09Likely Benign0.1-0.04Likely Benign0.03Likely Benign0.53Ambiguous-2.55Deleterious0.649Possibly Damaging0.240Benign3.41Benign0.13Tolerated3.373123-0.628.01
c.1925A>CK642T
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-12.823Likely Pathogenic0.948Likely PathogenicAmbiguous0.484Likely Benign0.53Ambiguous0.10.30Likely Benign0.42Likely Benign0.28Likely Benign-5.88Deleterious0.872Possibly Damaging0.839Possibly Damaging2.86Benign0.00Affected3.37310-13.2-27.07213.5-8.7-0.30.40.30.2XUncertainThe amino side chain of Lys642, located on the surface of an α helix (res. Ser641-Glu666), is not involved in any interactions in the WT simulations. In the variant simulations, the shorter side chain of Thr642 forms hydrogen bonds with Glu643 and Thr640 on the same α helix.Regardless, Lys642 is positioned directly at the GAP-Ras interface, and in the SynGAP-Ras WT simulations, its amino side chain forms salt bridges with the carboxylate groups of Ras residues Asp33 and Asp38. The shorter Thr642 is more likely to prefer hydrogen bonding with Glu643 and Thr640 on the same α helix, even in the Ras complex. Thus, the effect of the residue swap on the complex formation with the GTPase cannot be explored using solvent-only simulations.
c.1942T>CF648LLikely PathogenicGAPUncertain 1-9.296Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.468Likely Benign2.71Destabilizing0.82.08Destabilizing2.40Destabilizing1.04Destabilizing-5.98Deleterious0.999Probably Damaging0.976Probably Damaging3.45Benign0.08Tolerated201.0-34.02
c.1998G>CE666D
(3D Viewer)
Likely PathogenicGAPUncertain 1-8.820Likely Pathogenic0.704Likely PathogenicLikely Benign0.197Likely Benign0.88Ambiguous0.00.37Likely Benign0.63Ambiguous1.05Destabilizing-2.69Deleterious0.992Probably Damaging0.603Possibly Damaging3.43Benign0.06Tolerated3.3828320.0-14.03237.216.50.00.0-0.30.1XPotentially PathogenicThe carboxylate group of Glu666, located on the α-helix (res. Ser641-Glu666), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), such as Lys566, Thr672, and Asn669, in the WT simulations. In the variant simulations, the shorter side chain of Asp666 cannot maintain these interactions as efficiently as Glu666 in the WT, resulting in a less coordinated hydrogen-bond network.
c.2003C>TS668F
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-15.047Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.643Likely Pathogenic16.72Destabilizing5.011.07Destabilizing13.90Destabilizing0.00Likely Benign-5.98Deleterious0.999Probably Damaging0.935Probably Damaging3.18Benign0.00Affected3.3828-3-23.660.10250.9-59.6-0.10.10.00.1XXXPotentially PathogenicIn the WT simulations, the hydroxyl side chain of Ser668, located on an α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), forms hydrogen bonds with the backbone carbonyl groups of Leu664, Tyr665, and Glu666, as well as the guanidinium group of Arg573 on a nearby α-helix (res. Arg563-Glu578). In the variant simulations, the side chain of Phe668 cannot maintain the same hydrogen-bond network. Due to its larger size, it moves away to avoid steric hindrance. In the WT simulations, a network of hydrogen bonds between several residues (e.g., Asn669, Lys566, and Glu666) keeps both α-helices and the proceeding loop (res. Asn669-Asp684) tightly connected, but this setup is not present in the variant simulations. Additionally, in the variant simulations, the side chain of Arg573 shifts to form a more stable salt bridge with the carboxylate group of Glu582 instead of hydrogen bonding with Ser668 as in the WT simulations.
c.558G>CL186FLikely PathogenicUncertain 1-11.861Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.132Likely Benign-3.03Deleterious0.009Benign0.012Benign3.50Benign0.00Affected20-1.034.02
c.2105A>GQ702R
(3D Viewer)
GAPUncertain 1-7.894In-Between0.348AmbiguousLikely Benign0.294Likely Benign-0.31Likely Benign0.10.63Ambiguous0.16Likely Benign0.13Likely Benign-3.14Deleterious0.909Possibly Damaging0.889Possibly Damaging3.43Benign0.02Affected3.471011-1.028.06270.3-52.90.00.00.00.1XPotentially PathogenicThe carboxamide side chain of Gln702 is located at the end and outer surface of an α-helix (res. Leu685-Gln702), where it does not directly form hydrogen bonds with any residues in the WT simulations. In the variant simulations, the positively charged guanidinium group of Arg702 forms a salt bridge with the negatively charged carboxylate group of Glu698 on the same helix and/or hydrogen bonds with the backbone carbonyl group of Ala438 on an opposite α-helix (res. Tyr428-Glu436). Consequently, the residue swap could strengthen the tertiary structure assembly, which could have either positive or negative effects on its function.
c.2111G>CS704T
(3D Viewer)
Likely BenignGAPUncertain 1-4.930Likely Benign0.265Likely BenignLikely Benign0.071Likely Benign0.80Ambiguous0.00.15Likely Benign0.48Likely Benign0.29Likely Benign-1.72Neutral0.525Possibly Damaging0.107Benign3.45Benign0.07Tolerated3.4710110.114.03201.7-18.00.00.0-0.20.7XPotentially BenignSer704 is located at the end and outer surface of an α-helix (res. Thr704-Gly712), which is connected via a tight turn or loop to another α-helix (res. Asp684-Gln702). The hydroxyl side chain of Ser704 occasionally forms a hydrogen bond with the amide group of Ala707. Similarly, in the variant simulations, the hydroxyl side chain of Thr704 forms hydrogen bonds with the amide groups of Ala707 and Leu708. Thus, the residue swap does not cause any apparent structural change.
c.509G>AR170QPathogenic/Likely path. 6-9.021Likely Pathogenic0.798Likely PathogenicAmbiguous0.221Likely Benign-2.31Neutral0.947Possibly Damaging0.342Benign3.91Benign0.00Affected3.744111.0-28.0610.1016/j.ajhg.2020.11.011
c.2115G>CK705N
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-9.767Likely Pathogenic0.925Likely PathogenicAmbiguous0.183Likely Benign0.74Ambiguous0.00.37Likely Benign0.56Ambiguous0.44Likely Benign-3.12Deleterious0.996Probably Damaging0.876Possibly Damaging3.37Benign0.02Affected3.4710100.4-14.07221.4-20.20.00.00.00.1XUncertainThe amino side chain of Lys705, located at the end and outer surface of an α-helix (res. Thr704-Gly712), does not form any interactions in the WT simulations. In the variant simulations, the carboxamide side chain of Asn705 briefly forms a salt bridge with Glu706. However, there is no apparent difference between the systems. Due to the model ending abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2116G>AE706K
(3D Viewer)
GAPUncertain 1-10.519Likely Pathogenic0.833Likely PathogenicAmbiguous0.080Likely Benign1.17Ambiguous0.10.51Ambiguous0.84Ambiguous0.08Likely Benign-1.51Neutral0.345Benign0.028Benign4.15Benign0.52Tolerated3.471001-0.4-0.94187.149.20.00.00.40.1XUncertainThe carboxylate side chain of Glu706, located at the end and outer surface of an α-helix (res. Thr704-Gly712), forms a salt bridge with Lys710 and a hydrogen bond with its own backbone amino group at the helix end in the WT simulations. Although Lys706 is unable to make these transient interactions in the variant simulations, there is no apparent negative effect on the protein structure due to the residue swap. However, because the model ends abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.508C>TR170WLikely PathogenicUncertain 2-11.660Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.241Likely Benign-4.28Deleterious0.999Probably Damaging0.849Possibly Damaging3.84Benign0.00Affected3.7442-33.630.03
c.505G>AD169NUncertain 1-10.713Likely Pathogenic0.761Likely PathogenicLikely Benign0.110Likely Benign-2.04Neutral0.079Benign0.052Benign4.07Benign0.01Affected3.744210.0-0.98
c.2162T>GI721S
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.032Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.466Likely Benign3.91Destabilizing0.13.96Destabilizing3.94Destabilizing2.28Destabilizing-5.26Deleterious1.000Probably Damaging1.000Probably Damaging2.21Pathogenic0.00Affected3.509-1-2-5.3-26.08203.349.3-0.10.0-1.10.0XUncertainThe sec-butyl side chain of Ile721, located on an α-helix (res. Leu714-Arg726), engages in hydrophobic packing with other residues in the hydrophobic inter-helix space, such as Phe420, Tyr417, His693, and Leu717. In the variant simulations, the hydroxyl side chain of Ser721 forms hydrogen bonds with nearby residues, such as Leu717 and His693. Although no major structural changes are observed during the variant simulations, the hydrophilic residue Ser721 could disrupt the hydrophobic packing during folding. However, because the model ends abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2186A>GN729S
(3D Viewer)
Likely BenignGAPUncertain 1-1.578Likely Benign0.066Likely BenignLikely Benign0.063Likely Benign0.14Likely Benign0.11.34Ambiguous0.74Ambiguous-0.36Likely Benign-0.42Neutral0.221Benign0.027Benign3.38Benign0.93Tolerated3.597112.7-27.03
c.484C>TR162CPathogenic 2-8.157Likely Pathogenic0.787Likely PathogenicAmbiguous0.150Likely Benign-2.05Neutral0.988Probably Damaging0.513Possibly Damaging4.00Benign0.11Tolerated3.744-4-37.0-53.05
c.526A>CS176RLikely BenignUncertain 1-6.492Likely Benign0.987Likely PathogenicLikely Pathogenic0.247Likely Benign0.94Neutral0.718Possibly Damaging0.168Benign4.16Benign0.87Tolerated0-1-3.769.11
c.2087T>CL696P
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-16.926Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.678Likely Pathogenic6.66Destabilizing0.210.84Destabilizing8.75Destabilizing2.13Destabilizing-6.58Deleterious1.000Probably Damaging1.000Probably Damaging3.00Benign0.00Affected3.4613-3-3-5.4-16.04180.665.90.10.0-0.60.1XPotentially PathogenicThe isobutyl side chain of Leu696, located in the middle of an α-helix (res. Leu685-Gln702), engages in hydrophobic packing with nearby residues (e.g., Leu441, Leu431, Leu692, Leu714) in the inter-helix space. Prolines lack a free amide group necessary for hydrogen bonding with the carbonyl group of Leu692 in the same manner as Leu696 in the WT. Consequently, the residue swap with proline disrupts the continuity of the secondary structure element in the variant simulations. Additionally, the side chain of Pro696 is not as optimal as Leu696 for hydrophobic packing in the inter-helix space.
c.2015C>AT672K
(3D Viewer)
Likely PathogenicGAPUncertain 1-12.192Likely Pathogenic0.698Likely PathogenicLikely Benign0.065Likely Benign0.20Likely Benign0.51.21Ambiguous0.71Ambiguous0.72Ambiguous-4.31Deleterious0.745Possibly Damaging0.051Benign3.40Benign0.07Tolerated3.40250-1-3.227.07195.17.00.40.70.40.1XXPotentially PathogenicThe hydroxyl group of Thr672, located in an entangled α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop itself, such as Lys566, Glu666, and Asn669. In the variant simulations, Lys672 can only form a hydrogen bond with the amino group of the Lys566 side chain via its backbone carbonyl group. Consequently, it cannot maintain the Lys566-Glu666 salt bridge through hydrogen bonding. However, the amino group of Lys periodically forms a salt bridge with the carboxylate group of Glu666, which prevents a drastic disruption of the hydrogen-bond network that keeps the loop close to the helices.
c.2029A>TS677C
(3D Viewer)
Likely BenignGAPBenign 1-8.496Likely Pathogenic0.076Likely BenignLikely Benign0.153Likely Benign-0.51Ambiguous0.3-0.30Likely Benign-0.41Likely Benign0.15Likely Benign-2.41Neutral0.932Possibly Damaging0.222Benign3.25Benign0.04Affected3.4123-103.316.06
c.2050G>AD684N
(3D Viewer)
Likely PathogenicGAPUncertain 1-13.155Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.382Likely Benign1.47Ambiguous0.81.76Ambiguous1.62Ambiguous0.37Likely Benign-4.99Deleterious0.999Probably Damaging0.746Possibly Damaging3.39Benign0.01Affected210.0-0.98
c.2050G>CD684H
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.194Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.613Likely Pathogenic3.36Destabilizing1.02.95Destabilizing3.16Destabilizing0.55Ambiguous-6.98Deleterious1.000Probably Damaging0.972Probably Damaging3.36Benign0.00Affected3.4217-110.322.05
c.2060G>AR687Q
(3D Viewer)
Likely PathogenicGAPLikely Benign 1-10.002Likely Pathogenic0.575Likely PathogenicLikely Benign0.401Likely Benign0.92Ambiguous0.1-0.37Likely Benign0.28Likely Benign1.55Destabilizing-3.37Deleterious1.000Probably Damaging0.844Possibly Damaging3.91Benign0.03Affected3.4217111.0-28.06
c.2068T>CS690P
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.568Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.431Likely Benign4.84Destabilizing0.34.40Destabilizing4.62Destabilizing1.42Destabilizing-4.77Deleterious0.998Probably Damaging0.790Possibly Damaging3.44Benign0.01Affected3.42171-1-0.810.04207.515.10.10.0-0.10.2XXPotentially PathogenicThe hydroxyl side chain of Ser690, located in an α-helix (res. Leu696-Leu685), forms a hydrogen bond with the backbone carbonyl group of Ser410 in an anti-parallel β-sheet of the C2 domain (res. Ile411-Ala399). In the variant simulations, the pyrrolidine side chain of Pro690 cannot form hydrogen bonds with the C2 domain residue, resulting in the loss of this inter-domain connection. Additionally, prolines lack a free amide group necessary for hydrogen bonding with the carbonyl group of Gly686, introducing a slight bend in the α-helix and compromising its integrity.
c.2071A>CT691P
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-13.801Likely Pathogenic0.905Likely PathogenicAmbiguous0.214Likely Benign5.04Destabilizing0.46.09Destabilizing5.57Destabilizing1.27Destabilizing-3.43Deleterious1.000Probably Damaging0.952Probably Damaging3.43Benign0.06Tolerated3.43140-1-0.9-3.99188.933.00.10.0-0.60.0XXPotentially PathogenicThe hydroxyl side chain of Thr691, located in an α-helix (res. Leu696-Leu685), can form hydrogen bonds with the backbone carbonyl and the side chain guanidinium group of Arg687. This interaction facilitates the simultaneous formation of salt bridges between Arg687 and Glu688 on the same α-helix. Additionally, Thr691 occasionally interacts with the thioether side chain of Met409 in an anti-parallel β-sheet of the C2 domain (res. Ile411-Ala399), although this interaction is not consistently maintained throughout the WT simulations. In the variant simulations, the pyrrolidine side chain of Pro691 lacks hydrogen bond donors, making a similar setup impossible. Moreover, proline lacks a free amide group necessary for hydrogen bonding with the carbonyl group of Arg687, introducing a slight bend in the α-helix and compromising its integrity.
c.2075T>AL692Q
(3D Viewer)
Likely PathogenicGAPPathogenic 1-13.873Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.596Likely Pathogenic3.24Destabilizing0.13.27Destabilizing3.26Destabilizing2.76Destabilizing-5.98Deleterious1.000Probably Damaging0.998Probably Damaging3.06Benign0.00Affected3.4217-2-2-7.314.97
c.2075T>CL692P
(3D Viewer)
Likely PathogenicGAPUncertain 1-16.447Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.668Likely Pathogenic9.19Destabilizing0.113.20Destabilizing11.20Destabilizing1.69Destabilizing-6.98Deleterious1.000Probably Damaging0.999Probably Damaging3.06Benign0.00Affected3.4217-3-3-5.4-16.04186.262.8-0.20.1-0.70.3XPotentially PathogenicThe isobutyl side chain of Leu692, located in the middle of an α-helix (res. Leu685-Gln702), engages in hydrophobic packing with nearby residues (e.g., Leu441, Leu431, Leu696) in the inter-helix space. Prolines lack a free amide group necessary for hydrogen bonding with the carbonyl group of Glu688 in the same manner as Leu692 in the WT. Consequently, the residue swap with proline disrupts the continuity of the secondary structure element in the variant simulations. Additionally, the side chain of Pro692 is not as optimal as Leu692 for hydrophobic packing in the inter-helix space.
c.2086C>GL696V
(3D Viewer)
Likely PathogenicGAPUncertain 1-11.909Likely Pathogenic0.745Likely PathogenicLikely Benign0.351Likely Benign2.35Destabilizing0.11.85Ambiguous2.10Destabilizing1.46Destabilizing-2.79Deleterious0.992Probably Damaging0.970Probably Damaging3.16Benign0.00Affected3.4613120.4-14.03
c.2195G>CR732TUncertain 1-8.545Likely Pathogenic0.434AmbiguousLikely Benign0.075Likely Benign-1.96Neutral0.999Probably Damaging0.892Possibly Damaging2.59Benign0.12Tolerated3.597-1-13.8-55.08
c.2459A>GY820CLikely PathogenicUncertain 1-8.797Likely Pathogenic0.744Likely PathogenicLikely Benign0.113Likely Benign-3.16Deleterious1.000Probably Damaging0.983Probably Damaging2.68Benign0.06Tolerated3.7750-23.8-60.04
c.3287A>CE1096ALikely BenignUncertain 1-4.504Likely Benign0.510AmbiguousLikely Benign0.164Likely Benign-1.37Neutral0.626Possibly Damaging0.184Benign2.77Benign0.16Tolerated3.775-105.3-58.04
c.3209_3210delinsCAR1070TLikely BenignUncertain 1-5.093Likely Benign0.860Likely PathogenicAmbiguous-2.35Neutral0.948Possibly Damaging0.507Possibly Damaging3.78Benign0.01Affected3.775-1-13.8-55.08
c.3209G>AR1070KLikely BenignConflicting 2-5.093Likely Benign0.326Likely BenignLikely Benign0.104Likely Benign-1.42Neutral0.049Benign0.048Benign3.86Benign0.09Tolerated3.775320.6-28.01
c.2822C>TP941LLikely BenignUncertain 2-5.692Likely Benign0.066Likely BenignLikely Benign0.054Likely Benign-0.44Neutral0.144Benign0.039Benign2.76Benign0.01Affected-3-35.416.04
c.3196C>TP1066SLikely BenignLikely Pathogenic 1-4.746Likely Benign0.070Likely BenignLikely Benign0.145Likely Benign-2.47Neutral0.972Probably Damaging0.850Possibly Damaging2.74Benign0.00Affected4.3221-10.8-10.04
c.3192G>CQ1064HLikely BenignUncertain 1-4.576Likely Benign0.162Likely BenignLikely Benign0.063Likely Benign-0.66Neutral0.938Possibly Damaging0.596Possibly Damaging4.15Benign0.05Affected300.39.01
c.3181G>AG1061SLikely BenignUncertain 1-4.891Likely Benign0.079Likely BenignLikely Benign0.283Likely Benign-0.68Neutral0.004Benign0.004Benign4.00Benign0.00Affected10-0.430.03
c.3170G>AS1057NLikely BenignUncertain 1-6.386Likely Benign0.117Likely BenignLikely Benign0.218Likely Benign-0.41Neutral0.451Benign0.129Benign5.25Benign0.28Tolerated11-2.727.03
c.3161G>AG1054DUncertain 1-10.385Likely Pathogenic0.351AmbiguousLikely Benign0.279Likely Benign-0.26Neutral0.818Possibly Damaging0.266Benign4.07Benign0.37Tolerated3.7751-1-3.158.04
c.3154G>AG1052RUncertain 1-9.050Likely Pathogenic0.383AmbiguousLikely Benign0.497Likely Benign-0.41Neutral0.990Probably Damaging0.798Possibly Damaging3.90Benign0.10Tolerated3.775-2-3-4.199.14
c.2852A>GH951RLikely BenignLikely Pathogenic 1-4.964Likely Benign0.125Likely BenignLikely Benign0.185Likely Benign-1.08Neutral0.048Benign0.029Benign5.46Benign0.24Tolerated3.77520-1.319.05
c.2812G>AG938RLikely BenignUncertain 1-5.271Likely Benign0.732Likely PathogenicLikely Benign0.141Likely Benign-1.11Neutral0.999Probably Damaging0.985Probably Damaging2.74Benign0.36Tolerated3.775-3-2-4.199.14
c.2809G>CD937HLikely BenignUncertain 1-0.733Likely Benign0.677Likely PathogenicLikely Benign0.150Likely Benign-1.74Neutral1.000Probably Damaging0.975Probably Damaging2.68Benign0.13Tolerated3.775-110.322.05
c.3262A>GS1088GLikely BenignUncertain 1-5.034Likely Benign0.285Likely BenignLikely Benign0.163Likely Benign-1.83Neutral0.979Probably Damaging0.973Probably Damaging2.63Benign0.03Affected3.775010.4-30.03
c.3260C>TS1087FUncertain 1-3.843Likely Benign0.497AmbiguousLikely Benign0.105Likely Benign-2.75Deleterious0.990Probably Damaging0.796Possibly Damaging2.56Benign0.03Affected3.775-2-33.660.10
c.272A>GE91GLikely BenignLikely Benign 1-3.226Likely Benign0.783Likely PathogenicLikely Benign0.110Likely Benign-2.18Neutral0.947Possibly Damaging0.727Possibly Damaging3.86Benign0.00Affected4.3210-23.1-72.06
c.2735C>AT912NLikely BenignUncertain 1-4.260Likely Benign0.190Likely BenignLikely Benign0.116Likely Benign-1.15Neutral0.999Probably Damaging0.977Probably Damaging3.96Benign0.00Affected3.77500-2.813.00
c.2741A>TD914VLikely BenignUncertain 1-4.260Likely Benign0.723Likely PathogenicLikely Benign0.187Likely Benign-2.24Neutral0.999Probably Damaging0.986Probably Damaging2.64Benign0.01Affected3.775-3-27.7-15.96
c.3237C>GS1079RLikely BenignBenign 1-4.579Likely Benign0.955Likely PathogenicAmbiguous0.124Likely Benign-1.81Neutral0.177Benign0.075Benign3.86Benign0.00Affected3.7750-1-3.769.11
c.3233T>AV1078DLikely BenignUncertain 1-5.155Likely Benign0.979Likely PathogenicLikely Pathogenic0.158Likely Benign-1.45Neutral0.003Benign0.008Benign3.84Benign0.00Affected3.775-3-2-7.715.96
c.3223C>AQ1075KLikely BenignUncertain 1-5.135Likely Benign0.728Likely PathogenicLikely Benign0.134Likely Benign-0.67Neutral0.963Probably Damaging0.959Probably Damaging2.75Benign1.00Tolerated3.77511-0.40.04
c.2768T>AI923NLikely BenignUncertain 1-0.733Likely Benign0.712Likely PathogenicLikely Benign0.108Likely Benign-1.16Neutral0.991Probably Damaging0.793Possibly Damaging2.70Benign0.13Tolerated3.775-2-3-8.00.94
c.277C>GR93GLikely BenignUncertain 1-2.674Likely Benign0.400AmbiguousLikely Benign0.093Likely Benign-1.69Neutral0.103Benign0.019Benign3.99Benign0.00Affected4.321-2-34.1-99.14
c.3151G>TG1051CLikely Pathogenic 1-9.050Likely Pathogenic0.122Likely BenignLikely Benign0.497Likely Benign-0.90Neutral0.971Probably Damaging0.750Possibly Damaging-0.74Pathogenic0.10Tolerated3.775-3-32.946.09
c.2855G>TG952VLikely BenignUncertain 1-7.074In-Between0.078Likely BenignLikely Benign0.231Likely Benign-0.33Neutral0.000Benign0.000Benign3.20Benign0.02Affected3.775-1-34.642.08
c.2858C>AP953QLikely BenignUncertain 1-6.038Likely Benign0.079Likely BenignLikely Benign0.086Likely Benign-0.78Neutral0.058Benign0.015Benign2.78Benign0.29Tolerated3.7750-1-1.931.01
c.2932C>TP978SLikely BenignUncertain 1-3.913Likely Benign0.151Likely BenignLikely Benign0.085Likely Benign-1.07Neutral0.481Possibly Damaging0.220Benign4.22Benign0.48Tolerated1-10.8-10.04
c.2935T>CF979LLikely BenignUncertain 1-2.341Likely Benign0.870Likely PathogenicAmbiguous0.228Likely Benign-1.00Neutral0.625Possibly Damaging0.430Benign4.22Benign0.73Tolerated4.322201.0-34.02
c.3020G>AS1007NLikely BenignBenign 1-5.113Likely Benign0.803Likely PathogenicAmbiguous0.075Likely Benign-1.54Neutral0.997Probably Damaging0.992Probably Damaging2.65Benign0.01Affected3.77511-2.727.03
c.3009C>GS1003RUncertain 1-5.113Likely Benign0.991Likely PathogenicLikely Pathogenic0.141Likely Benign-1.88Neutral0.999Probably Damaging0.996Probably Damaging2.48Pathogenic0.00Affected3.7750-1-3.769.11
c.2954G>AS985NLikely BenignUncertain 1-6.979Likely Benign0.845Likely PathogenicAmbiguous0.088Likely Benign-1.68Neutral0.991Probably Damaging0.988Probably Damaging2.65Benign0.00Affected4.32111-2.727.03
c.2960A>GD987GLikely PathogenicUncertain 1-4.782Likely Benign0.849Likely PathogenicAmbiguous0.234Likely Benign-2.79Deleterious0.943Possibly Damaging0.808Possibly Damaging2.45Pathogenic0.07Tolerated4.3221-13.1-58.04
c.3002T>CL1001PLikely BenignUncertain 1-3.071Likely Benign0.209Likely BenignLikely Benign0.113Likely Benign-1.02Neutral0.966Probably Damaging0.690Possibly Damaging2.65Benign0.00Affected4.324-3-3-5.4-16.04
c.2983C>TP995SLikely BenignUncertain 1-4.457Likely Benign0.071Likely BenignLikely Benign0.042Likely Benign-1.03Neutral0.011Benign0.015Benign4.24Benign0.00Affected4.3211-10.8-10.04
c.2987C>GP996RLikely BenignBenign 1-4.457Likely Benign0.141Likely BenignLikely Benign0.040Likely Benign-1.04Neutral0.144Benign0.085Benign4.26Benign0.01Affected4.324-20-2.959.07
c.2989G>AA997TLikely BenignUncertain 1-4.102Likely Benign0.071Likely BenignLikely Benign0.085Likely Benign-0.62Neutral0.224Benign0.120Benign4.17Benign0.00Affected4.32410-2.530.03
c.2928T>GF976LLikely BenignUncertain 1-2.432Likely Benign0.825Likely PathogenicAmbiguous0.212Likely Benign-0.87Neutral0.264Benign0.102Benign4.20Benign0.53Tolerated4.322201.0-34.02
c.3026A>CE1009ALikely PathogenicUncertain 1-3.118Likely Benign0.679Likely PathogenicLikely Benign0.109Likely Benign-3.06Deleterious0.980Probably Damaging0.630Possibly Damaging2.39Pathogenic0.01Affected3.7750-15.3-58.04
c.3142G>CG1048RLikely BenignUncertain 1-4.305Likely Benign0.435AmbiguousLikely Benign0.503Likely Pathogenic-0.54Neutral0.919Possibly Damaging0.728Possibly Damaging2.54Benign0.10Tolerated3.775-2-3-4.199.14
c.313T>CS105PLikely BenignUncertain 1-3.631Likely Benign0.166Likely BenignLikely Benign0.204Likely Benign0.03Neutral0.808Possibly Damaging0.212Benign4.00Benign0.00Affected4.321-11-0.810.04
c.3103C>AP1035TLikely BenignUncertain 1-4.447Likely Benign0.426AmbiguousLikely Benign0.087Likely Benign-0.96Neutral0.901Possibly Damaging0.537Possibly Damaging2.72Benign0.23Tolerated3.7750-10.93.99
c.3100C>GP1034ALikely BenignBenign 1-4.174Likely Benign0.178Likely BenignLikely Benign0.060Likely Benign-2.44Neutral0.059Benign0.061Benign2.47Pathogenic0.06Tolerated3.7751-13.4-26.04
c.3059G>TR1020LUncertain 1-6.031Likely Benign0.907Likely PathogenicAmbiguous0.216Likely Benign-4.03Deleterious0.990Probably Damaging0.921Probably Damaging2.50Benign0.00Affected3.775-3-28.3-43.03
c.3059G>CR1020PLikely PathogenicUncertain 1-3.491Likely Benign0.902Likely PathogenicAmbiguous0.205Likely Benign-3.50Deleterious0.999Probably Damaging0.977Probably Damaging2.46Pathogenic0.00Affected0-22.9-59.07
c.2909A>GE970GLikely BenignBenign 1-0.167Likely Benign0.139Likely BenignLikely Benign0.139Likely Benign-0.93Neutral0.144Benign0.058Benign4.09Benign0.10Tolerated4.3220-23.1-72.06
c.3049T>CF1017LLikely BenignBenign 1-2.048Likely Benign0.934Likely PathogenicAmbiguous0.157Likely Benign-2.38Neutral0.798Possibly Damaging0.373Benign2.65Benign0.72Tolerated3.775021.0-34.02
c.3041G>TG1014VLikely BenignUncertain 1-4.612Likely Benign0.181Likely BenignLikely Benign0.053Likely Benign-2.47Neutral0.818Possibly Damaging0.377Benign2.72Benign0.06Tolerated3.775-1-34.642.08
c.2924C>GT975SLikely BenignUncertain 1-2.743Likely Benign0.068Likely BenignLikely Benign0.109Likely Benign-0.57Neutral0.059Benign0.061Benign4.16Benign0.20Tolerated11-0.1-14.03
c.2998A>GI1000VLikely BenignUncertain 2-4.102Likely Benign0.098Likely BenignLikely Benign0.086Likely Benign-0.20Neutral0.437Benign0.170Benign2.76Benign0.81Tolerated4.32434-0.3-14.03
c.3290C>TP1097LLikely BenignBenign 1-4.410Likely Benign0.145Likely BenignLikely Benign0.131Likely Benign-2.07Neutral0.611Possibly Damaging0.198Benign2.64Benign0.05Affected3.775-3-35.416.04
c.3705G>AM1235ILikely BenignCoiled-coilUncertain 1-4.312Likely Benign0.310Likely BenignLikely Benign0.027Likely Benign-1.44Neutral0.139Benign0.056Benign2.69Benign0.04Affected3.775122.6-18.03
c.2557G>CG853RLikely BenignUncertain 1-4.749Likely Benign0.366AmbiguousLikely Benign0.091Likely Benign-1.27Neutral0.846Possibly Damaging0.624Possibly Damaging4.18Benign0.00Affected-3-2-4.199.14
c.3635C>TS1212FLikely PathogenicCoiled-coilConflicting 2-14.445Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.271Likely Benign-4.52Deleterious0.999Probably Damaging0.998Probably Damaging2.03Pathogenic0.00Affected3.775-3-23.660.10
c.502C>TH168YLikely BenignBenign 1-8.914Likely Pathogenic0.264Likely BenignLikely Benign0.065Likely Benign-1.53Neutral0.192Benign0.062Benign4.18Benign0.01Affected4.323021.926.03
c.3632T>AM1211KLikely PathogenicCoiled-coilLikely Benign 1-9.013Likely Pathogenic0.662Likely PathogenicLikely Benign0.595Likely Pathogenic-2.95Deleterious0.987Probably Damaging0.979Probably Damaging5.59Benign0.01Affected3.7750-1-5.8-3.02
c.256G>AV86ILikely BenignUncertain 1-4.726Likely Benign0.338Likely BenignLikely Benign0.076Likely Benign-0.31Neutral0.267Benign0.097Benign3.94Benign0.00Affected4.321430.314.03
c.3614T>CL1205PLikely PathogenicCoiled-coilUncertain 1-16.878Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.536Likely Pathogenic-5.91Deleterious1.000Probably Damaging0.999Probably Damaging1.45Pathogenic0.00Affected-3-3-5.4-16.04
c.3607C>GH1203DLikely BenignCoiled-coilUncertain 1-6.729Likely Benign0.525AmbiguousLikely Benign0.403Likely Benign-1.89Neutral0.473Possibly Damaging0.265Benign5.51Benign0.24Tolerated3.7751-1-0.3-22.05
c.3574C>GL1192VLikely BenignCoiled-coilUncertain 1-4.132Likely Benign0.471AmbiguousLikely Benign0.041Likely Benign-0.89Neutral0.779Possibly Damaging0.527Possibly Damaging2.69Benign0.16Tolerated210.4-14.03
c.3529G>AE1177KLikely BenignCoiled-coilUncertain 1-3.413Likely Benign0.944Likely PathogenicAmbiguous0.560Likely Pathogenic-1.75Neutral0.905Possibly Damaging0.637Possibly Damaging5.44Benign0.11Tolerated4.32201-0.4-0.94
c.3511_3512delinsTGA1171CLikely BenignCoiled-coilUncertain 1-5.363Likely Benign0.496AmbiguousLikely Benign-1.16Neutral0.978Probably Damaging0.825Possibly Damaging5.32Benign0.02Affected4.324-200.732.06
c.2548G>AG850RLikely BenignUncertain 1-5.082Likely Benign0.398AmbiguousLikely Benign0.194Likely Benign-0.07Neutral0.010Benign0.010Benign4.30Benign0.01Affected3.775-3-2-4.199.14
c.2525C>AS842YLikely PathogenicLikely Pathogenic 1-16.124Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.191Likely Benign-4.28Deleterious0.944Possibly Damaging0.676Possibly Damaging1.97Pathogenic0.00Affected3.775-3-2-0.576.10
c.2485G>AE829KLikely PathogenicPathogenic 1-7.527In-Between0.807Likely PathogenicAmbiguous0.194Likely Benign-2.65Deleterious0.994Probably Damaging0.900Possibly Damaging2.27Pathogenic0.00Affected3.77501-0.4-0.94
c.249A>TR83SLikely BenignUncertain 1-2.550Likely Benign0.999Likely PathogenicLikely Pathogenic0.094Likely Benign-1.87Neutral0.909Possibly Damaging0.587Possibly Damaging3.19Benign0.00Affected4.3210-13.7-69.11
c.2502G>CM834ILikely BenignUncertain 1-3.377Likely Benign0.291Likely BenignLikely Benign0.055Likely Benign-1.21Neutral0.026Benign0.009Benign2.56Benign0.00Affected4.324122.6-18.03
c.2503C>AL835MLikely BenignBenign 1-4.153Likely Benign0.121Likely BenignLikely Benign0.068Likely Benign-0.45Neutral0.999Probably Damaging0.977Probably Damaging2.67Benign0.12Tolerated3.77524-1.918.03
c.3686A>CQ1229PLikely PathogenicCoiled-coilUncertain 1-10.397Likely Pathogenic0.980Likely PathogenicLikely Pathogenic0.422Likely Benign-3.69Deleterious0.998Probably Damaging0.995Probably Damaging1.75Pathogenic0.12Tolerated3.7750-11.9-31.01
c.250C>GR84GUncertain 1-6.627Likely Benign0.989Likely PathogenicLikely Pathogenic0.139Likely Benign-2.64Deleterious0.962Probably Damaging0.726Possibly Damaging3.68Benign0.00Affected4.321-3-24.1-99.14
c.2514C>AN838KLikely PathogenicUncertain 2-8.470Likely Pathogenic0.862Likely PathogenicAmbiguous0.097Likely Benign-2.78Deleterious0.997Probably Damaging0.995Probably Damaging2.69Benign0.16Tolerated3.77510-0.414.07
c.2518A>TS840CLikely PathogenicUncertain 1-8.799Likely Pathogenic0.904Likely PathogenicAmbiguous0.376Likely Benign-3.96Deleterious0.999Probably Damaging0.975Probably Damaging1.50Pathogenic0.00Affected3.7750-13.316.06
c.3655T>CY1219HLikely PathogenicCoiled-coilUncertain 1-9.511Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.363Likely Benign-3.62Deleterious1.000Probably Damaging0.999Probably Damaging2.15Pathogenic0.00Affected3.77502-1.9-26.03
c.3653A>TE1218VLikely PathogenicCoiled-coilUncertain 2-5.647Likely Benign0.936Likely PathogenicAmbiguous0.418Likely Benign-5.68Deleterious1.000Probably Damaging0.998Probably Damaging2.21Pathogenic0.00Affected3.775-2-27.7-29.98
c.3511G>AA1171TLikely BenignCoiled-coilUncertain 1-3.658Likely Benign0.149Likely BenignLikely Benign0.201Likely Benign-0.48Neutral0.245Benign0.138Benign5.45Benign0.07Tolerated4.32410-2.530.03
c.2608C>GL870VLikely BenignUncertain 1-4.123Likely Benign0.300Likely BenignLikely Benign0.111Likely Benign-1.19Neutral0.997Probably Damaging0.992Probably Damaging2.64Benign0.12Tolerated3.883210.4-14.03
c.3508A>GS1170GLikely BenignCoiled-coilUncertain 1-4.288Likely Benign0.221Likely BenignLikely Benign0.349Likely Benign-0.81Neutral0.241Benign0.229Benign5.31Benign0.54Tolerated4.324100.4-30.03
c.266C>TP89LUncertain 2-6.775Likely Benign0.982Likely PathogenicLikely Pathogenic0.119Likely Benign-3.29Deleterious0.889Possibly Damaging0.058Benign3.73Benign0.00Affected4.321-3-35.416.04
c.3386T>CL1129PLikely BenignUncertain 2-2.991Likely Benign0.154Likely BenignLikely Benign0.432Likely Benign0.27Neutral0.971Probably Damaging0.773Possibly Damaging5.44Benign0.00Affected4.324-3-3-5.4-16.04
c.2684G>AS895NLikely BenignUncertain 1-6.399Likely Benign0.604Likely PathogenicLikely Benign0.118Likely Benign-0.85Neutral0.991Probably Damaging0.988Probably Damaging2.64Benign0.30Tolerated4.32411-2.727.03
c.2690C>TS897LLikely BenignUncertain 1-4.034Likely Benign0.299Likely BenignLikely Benign0.028Likely Benign-1.71Neutral0.901Possibly Damaging0.636Possibly Damaging2.66Benign0.01Affected-3-24.626.08
c.3377G>AG1126DUncertain 1-8.888Likely Pathogenic0.432AmbiguousLikely Benign0.376Likely Benign-0.65Neutral0.906Possibly Damaging0.473Possibly Damaging4.82Benign0.02Affected3.7751-1-3.158.04
c.269T>AV90ELikely BenignUncertain 1-4.079Likely Benign0.703Likely PathogenicLikely Benign0.108Likely Benign-0.38Neutral0.001Benign0.000Benign4.00Benign0.00Affected4.321-2-2-7.729.98
c.3354C>AS1118RLikely BenignUncertain 1-2.670Likely Benign0.553AmbiguousLikely Benign0.166Likely Benign-0.74Neutral0.034Benign0.023Benign5.17Benign0.05Affected4.322-10-3.769.11
c.3328A>GS1110GLikely BenignLikely Benign 1-4.674Likely Benign0.079Likely BenignLikely Benign0.035Likely Benign-2.26Neutral0.036Benign0.026Benign2.19Pathogenic0.08Tolerated4.322100.4-30.03
c.3326T>CL1109PLikely BenignConflicting 2-5.313Likely Benign0.120Likely BenignLikely Benign0.151Likely Benign-0.52Neutral0.002Benign0.003Benign2.65Benign0.07Tolerated4.322-3-3-5.4-16.04
c.2711T>CM904TLikely BenignUncertain 1-2.721Likely Benign0.668Likely PathogenicLikely Benign0.042Likely Benign-1.15Neutral0.277Benign0.103Benign2.78Benign0.18Tolerated3.775-1-1-2.6-30.09
c.3395C>AS1132YLikely BenignLikely Benign 1-5.894Likely Benign0.392AmbiguousLikely Benign0.401Likely Benign-1.76Neutral0.500Possibly Damaging0.208Benign5.40Benign0.09Tolerated4.324-3-2-0.576.10
c.3405G>CK1135NLikely BenignUncertain 1-5.715Likely Benign0.960Likely PathogenicLikely Pathogenic0.166Likely Benign-0.97Neutral0.411Benign0.321Benign5.43Benign0.07Tolerated4.322100.4-14.07
c.3502A>GI1168VLikely BenignUncertain 1-3.263Likely Benign0.524AmbiguousLikely Benign0.363Likely Benign-0.14Neutral0.876Possibly Damaging0.643Possibly Damaging5.47Benign0.84Tolerated3.88343-0.3-14.03
c.2627C>TS876LUncertain 2-5.856Likely Benign0.489AmbiguousLikely Benign0.249Likely Benign-3.56Deleterious0.998Probably Damaging0.992Probably Damaging2.57Benign0.05Affected3.775-2-34.626.08
c.2632A>GT878ALikely BenignUncertain 1-2.154Likely Benign0.081Likely BenignLikely Benign0.088Likely Benign-0.67Neutral0.003Benign0.006Benign2.73Benign0.18Tolerated3.775102.5-30.03
c.2635_2636delinsAAA879KLikely BenignLikely Benign 1-5.877Likely Benign0.757Likely PathogenicLikely Benign-0.71Neutral0.969Probably Damaging0.593Possibly Damaging2.69Benign0.21Tolerated3.775-1-1-5.757.10
c.263T>CV88ALikely BenignUncertain 1-5.860Likely Benign0.993Likely PathogenicLikely Pathogenic0.050Likely Benign-1.22Neutral0.053Benign0.008Benign3.75Benign0.00Affected4.32100-2.4-28.05
c.3494C>TS1165LLikely BenignConflicting 2-2.984Likely Benign0.793Likely PathogenicAmbiguous0.166Likely Benign-2.01Neutral0.998Probably Damaging0.992Probably Damaging2.60Benign0.33Tolerated3.883-3-24.626.0810.1016/j.ajhg.2020.11.011
c.3487C>GH1163DUncertain 1-2.107Likely Benign0.949Likely PathogenicAmbiguous0.476Likely Benign-2.60Deleterious0.991Probably Damaging0.991Probably Damaging5.44Benign0.31Tolerated3.8831-1-0.3-22.05
c.3484C>TP1162SLikely BenignUncertain 1-2.118Likely Benign0.913Likely PathogenicAmbiguous0.215Likely Benign-1.93Neutral1.000Probably Damaging0.999Probably Damaging2.73Benign0.55Tolerated3.8831-10.8-10.04
c.265C>GP89ALikely BenignUncertain 2-5.778Likely Benign0.920Likely PathogenicAmbiguous0.095Likely Benign-2.47Neutral0.225Benign0.020Benign3.77Benign0.00Affected4.3211-13.4-26.04
c.3442A>TM1148LLikely BenignUncertain 1-1.777Likely Benign0.093Likely BenignLikely Benign0.068Likely Benign-1.13Neutral0.016Benign0.016Benign2.62Benign0.00Affected4.322421.9-18.03
c.3304G>CA1102PLikely BenignUncertain 1-5.120Likely Benign0.077Likely BenignLikely Benign0.118Likely Benign-0.97Neutral0.000Benign0.002Benign2.26Pathogenic0.13Tolerated3.775-11-3.426.04
c.1367A>CQ456P
(3D Viewer)
Likely PathogenicGAPUncertain 1-15.250Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.469Likely Benign3.68Destabilizing0.28.43Destabilizing6.06Destabilizing0.82Ambiguous-5.66Deleterious1.000Probably Damaging0.999Probably Damaging3.34Benign0.07Tolerated3.3734-101.9-31.01

Found 757 rows. Show 200 rows per page. Page 1/4 |